Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Injecting hyaluronidase into the artery is effective for treating skin death and hair loss caused by hyaluronic acid fillers.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Acitretin effectively treats severe hypertrophic lichen planus.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Hormonal therapies effectively treat acne and improve quality of life.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Upadacitinib effectively treated severe hair loss in a child.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Topical finasteride may help improve hidradenitis suppurativa symptoms.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

HAIR-AN syndrome mainly affects obese women and can be improved with early diagnosis and treatment using insulin-sensitizing agents.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Most patients improved with oral contraceptives, but some needed additional treatment.

Hydroxychloroquine may help some hair disorders, but results vary.

Tacrolimus can cause hair loss in kidney transplant patients.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.